Proper protein folding is essential for function, while misfolding causes loss of function and disease. Proteins fold in a crowded cellular environment with high macromolecule concentrations that influence the folding process. How do proteins achieve correct folding in such complexity?
Over nearly 70 years, protein folding research has earned three Nobel Prizes in Chemistry: for determining the first protein structure (1962), discovering that primary sequence determines native structure—the Anfinsen dogma (1972), and advancing protein structure prediction and design (2024). Recent AI advances have dramatically improved our understanding of final protein structures. However, our knowledge of folding mechanisms and the factors governing how proteins reach these structures remains limited.
Chaperonins are essential molecular machines that safeguard protein homeostasis by assisting nascent and misfolded proteins to achieve their native conformations. Despite their critical role in cellular function, the molecular principles governing how chaperonins recognize diverse substrates, orchestrate the folding process, and prevent aggregation in the crowded cellular environment remain incompletely understood. Our research integrates structural biology, biochemistry, and cell biology to elucidate these problems with mechanistic details and to provide fundamental insights into protein quality control mechanisms with implications for understanding diseases caused by protein misfolding.
Chaperonin TRiC guides tubulin maturation, a critical step in microtubule function. As many cancers exploit aberrant microtubule dynamics, we are investigating how modulating TRiC‑mediated tubulin maturation can guide the development of targeted therapies. Integrating structural insights with engineering, we aim to fine‑tune TRiC activity to selectively influence tubulin maturation in tumor cells, with the goal of overcoming resistance to existing agents while minimizing off‑target effects.